50
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Enhanced antitumor efficacy of vitamin E TPGS-emulsified PLGA nanoparticles for delivery of paclitaxel.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Nanoparticles are efficient delivery vehicles for cancer therapy such as paclitaxel (PTX). In this study, we formulated PTX into PLGA polymeric nanoparticles. Vitamin E TPGS was used as an emulsifier to stabilize the nanoparticle formulation. PTX was encapsulated in TPGS-emulsified polymeric nanoparticles (TENPs) by a nanoprecipitation method in ethanol-water system. The resultant PTX-TENPs showed a very uniform particle size (∼100 nm) and high drug encapsulation (>80%). The cytotoxicity of PTX-TENPs was examined in A549 lung cancer cell line. Preferential tumor accumulation of TENPs was observed in the A549 lung cancer xenograft model. Tumor growth was significantly inhibited by intravenous injection of PTX-TENPs. Our results suggested that the modified nanoprecipitation method holds great potential for the fabrication of the PTX loaded polymeric nanoparticles. TPGS can be used in the manufacture of polymeric nanoparticles for the controlled release of PTX and other anti-cancer drugs.

          Related collections

          Author and article information

          Journal
          Colloids Surf B Biointerfaces
          Colloids and surfaces. B, Biointerfaces
          Elsevier BV
          1873-4367
          0927-7765
          Nov 01 2014
          : 123
          Affiliations
          [1 ] Department of Thoracic Surgery, First Hospital, China Medical University, Shenyang, Liaoning, PR China.
          [2 ] Hangzhou PushiKang Biotechnology Co., Ltd, Zhejiang, PR China.
          [3 ] The State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai 200237, PR China.
          [4 ] Mudanjiang Youbo Pharmaceutical Co., Ltd, Beijing, PR China.
          [5 ] Department of Pediatrics, PLA General Hospital, Beijing, PR China.
          [6 ] School of Life Sciences, Jinlin University, Changchun, PR China; College of Pharmacy, The Ohio State University, Columbus, OH, USA.
          [7 ] School of Life Sciences, Jinlin University, Changchun, PR China. Electronic address: tenglesheng@jlu.edu.cn.
          Article
          S0927-7765(14)00538-4
          10.1016/j.colsurfb.2014.10.007
          25456995
          fb6759c5-47dd-47a6-abd4-33b0ddc67ec7
          History

          Chemotherapy,Drug delivery,Lung cancer,Nanoparticles,Paclitaxel,TPGS

          Comments

          Comment on this article